Neuren Pharmaceuticals
NEU.AX
NZ$18.30
Share price
1.64%
Change (1 day)
-17.33%
Change (1 year)
Categories
EPS for Neuren Pharmaceuticals (NEU.AX)
EPS in 2023: NZ$1.41
According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.41. In 2023 the company made an earnings per share (EPS) of NZ$1.41 an increase over its 2022 EPS that were of NZ$0.001709.
EPS history for Neuren Pharmaceuticals from 2002 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 | NZ$1.41 | 82396.45% |
| 2022 | NZ$0.001709 | -102.13% |
| 2021 | NZ-$0.08012 | -27.64% |
| 2020 | NZ-$0.11 | -12.55% |
| 2019 | NZ-$0.13 | -446.24% |
| 2018 | NZ$0.03657 | -247.23% |
| 2017 | NZ-$0.02484 | -85.3% |
| 2016 | NZ-$0.17 | -13.42% |
| 2015 | NZ-$0.20 | 34.36% |
| 2014 | NZ-$0.15 | -47.14% |
| 2013 | NZ-$0.27 | 83.64% |
| 2012 | NZ-$0.15 | -28.56% |
| 2011 | NZ-$0.21 | -46.5% |
| 2010 | NZ-$0.39 | -3690.16% |
| 2009 | NZ$0.01091 | -100.76% |
| 2008 | NZ-$1.43 | -38.72% |
| 2007 | NZ-$2.34 | 11.23% |
| 2006 | NZ-$2.10 | 14.27% |
| 2005 | NZ-$1.84 | -42.59% |
| 2004 | NZ-$3.20 | 2.56% |
| 2003 | NZ-$3.12 | 36.5% |
| 2002 | NZ-$2.29 |